Latest Conference Articles

"Not only has it shown efficacy in atopic dermatitis, but dupilumab also has shown efficacy in related atopic dermatitis conditions such as asthma and nasal polyps," said Akinlade.

Bola Akinlade, MD, MBA, Executive Director, Regeneron Pharmaceuticals, discussed the results of the dupilumab study presented at AAAAI 2017.

Jared Ditkowsky, MD, SUNY Downstate, explained the connotations surrounding the development of a potential vaccine for Chlamydia trachomatis (C. trachomatis), the infection causing chlamydia - one of the most common bacterial sexually transmitted infections in the United States.

The phase 3b MUSCA trial reported positive results for mepolizumab.

Jared Ditkowsky, MD candidate, SUNY Downstate explained that many of the problems surrounding a potential chlamydia vaccine are immunologic in nature.

Do emergency department physicians follow the asthma care guidelines?

Researchers analyze walnut immunotherapy outcomes at 142 weeks.

Jay Jin, MD, PhD, Mayo Clinic, shared the results from his team's case series surrounding unexpected bradycardia effect from epinephrine administration.

Females were less likely to be compliant, a contradiction to previous research.

Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases (NIAID), shared with MD Magazine what the main theme would be in his keynote address at the AAAAI 2017 meeting in Atlanta, GA: emerging and reemerging infections, a perpetual challenge.

Only a small percentage of people who think they have a penicillin allergy actually do.

How safe are anti-inflammatory medications for children?

Mark S. Forshag, MD, MHA, with GSK, shared some of his team's next steps in advancing asthma care specifically with trying to keep things simple for the patients and their physicians.

Mark S. Forshag, MD, MHA, GSK, spoke with MD Magazine at AAAAI 2017 in Atlanta, GA, about the importance of eosinophils in treating severe asthma.

A chlamydia vaccine would cut infection rates, but cost millions.

The SQ HDM SLIT-tablet is already approved in Europe. Is the US next?

The study was conducted in patients with grass pollen-induced allergic rhinoconjunctivitis.

Would carrying a rescue inhaler correlate with better asthma control? That's what Sima J. Patel, DO and her team sought to investigate.

Trial results on novel multi-dose powder inhaler were revealed at AAAAI 2017.

Luz Fonacier, MD, Winthrop University Hospital, detailed the process of looking at eczema and contact dermatitis in an allergist's practice.

In an ideal world, interventions would have a pilot study before RCT.

Which recommendations decrease asthma morbidity in children with asthma?

Matthew Perzanowski, PhD, discusses allergic asthma environmental factors.

Katia Boven, MD, Head of Clinical Development and Global Medical Affairs, Infectious Diseases, Janssen, discussed results and impact of the SWORD clinical trial involving the investigational two-drug combination being as effective as the three or four regimens as maintenance therapy in HIV patients who have already achieved viral suppression.

One team's goal at the US Military HIV research Program is to control plasma viral load in the blood to undetectable levels without the use of long-term ART.

"We've done a really good job of developing medicines to get that virus under control. I think what's sort of important for our community now is to very carefully look at what the unmet needs are," said Emu.

Adding an extra 20,000 IU vitamin D2 a week didn't make a difference.

"Even though we have a lot of drugs, because of the resistance profile of their virus, they don't have a lot of options, so what these results mean for the most vulnerable of our patients is that they have access now to a new class of drugs," Emu concluded.

HIV, hepatitis C coinfections weren't all that uncommon at a Bronx ER.